Oxalic Acid

Oxalic Acid

SCHEMBL6486537

CCCCCCN1CCN(CC(O)c2ccnc3ccc(OC)cc23)CC1.O=C(O)C(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 8/20 0.60
KCNH2 Q12809 2/20 0.49
CCR8 P51685 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL6484327 1.00 SLC2A1 (0.60) SLC2A1KCNH2CCR8
Oxalic Acid SCHEMBL6486545 1.00 SLC2A1 (0.60) SLC2A1KCNH2CCR8
Oxalic Acid SCHEMBL6484323 1.00 SLC2A1 (0.60) SLC2A1KCNH2CCR8
Oxalic Acid SCHEMBL6484824 1.00 SLC2A1 (0.60) SLC2A1KCNH2CCR8
Oxalic Acid SCHEMBL6484821 1.00 SLC2A1 (0.60) SLC2A1KCNH2CCR8
Oxalic Acid SCHEMBL6486309 1.00 SLC2A1 (0.60) SLC2A1KCNH2CCR8
SCHEMBL6498402 0.95 SLC2A1 (0.60) SLC2A1KCNH2CCR8
SCHEMBL6645394 0.95 SLC2A1 (0.60) SLC2A1KCNH2CCR8
SCHEMBL6645390 0.95 SLC2A1 (0.60) SLC2A1KCNH2CCR8
SCHEMBL6645387 0.95 SLC2A1 (0.60) SLC2A1KCNH2CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6911442-B1 Quinoline derivatives as antibacterials SMITHKLINE BEECHAM P.L.C. (GB) 2005-06-28 US claimed
EP-1187828-B1 QUINOLINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2004-04-21 EP claimed
EP-1187828-B1 QUINOLINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2004-04-21 EP disclosed
EP-1187828-A1 QUINOLINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM PLC (GB) 2002-03-20 EP disclosed
WO-2000078748-A1 QUINOLINE DERIVATIVES AS ANTIBACTERIALS SMITHKLINE BEECHAM P.L.C. (GB) 2000-12-28 WO disclosed